Vertex

Vertex Pharmaceuticals (VRTX) is scheduled to announce Q3 earnings results on Monday, November 2, after market close. The consensus EPS estimate is $4.75 (-1.0% Y/Y), and the consensus revenue estimate…

ESGold   is based on a replicable growth model, built for scale and designed to overcome the high failure rate among junior miners. With funding in place, the company has…

Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.